Kara N. Maxwell, MD, PhD, discusses the risk of cancer for males carrying BRCA mutations.
Kara N. Maxwell, MD, PhD
Advertisement
Articles by Kara N. Maxwell, MD, PhD
Kara N. Maxwell, MD, PhD, discusses key takeaways from a real-world investigation of germline mutation rates in patients with metastatic prostate cancer.
Kara N. Maxwell, MD, PhD, discusses the accessibility of genetic testing in the community setting for patients with metastatic prostate cancer.
Kara N. Maxwell, MD, PhD, discusses strategies to optimize the utility of genetic testing to better inform decision-making in prostate cancer treatment.
Kara Maxwell, MD, PhD discusses a study of genetic testing results in metastatic prostate cancer.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
Dr Pant on the Potential Significance of Daraxonrasib for PDAC Management
2
Breast Cancer Buzz at ASCO 2026: De-Escalation Strategies, Targeted Therapies, and More
3
Dr Cummings on the Utility of Adjuvant Immunotherapy Alone in Early-Stage NSCLC
4
Dr Lee on the Optimal Duration of Adjuvant Osimertinib in EGFR+ NSCLC
5